contents · 2017-01-26 · highlights for this reporting quarter in this reporting quarter, 21...

I

CONTENTS

Acronyms ....................................................................................................................................II

Acknowledgments ......................................................................................................................III

Background ............................................................................................................................... IV

Executive Summary .....................................................................................................................1

Reporting Rates (Table 1A) ..........................................................................................................3

Reporting Details by Provinces and NGOs (Table 1B) ...................................................................4

The Summary of Overall Value Indicators (Table 2A) ...................................................................6

The Summary of Value Indicators by Levels (Table 2B) ................................................................7

The Consumed Value of HMIS Indicator Medicines for MIAR (Table 2C) ....................................11

The Consumed Value of HMIS Indicator Medicines for HMIR (Table 2D) ...................................12

The Consumed Value of RMNCH Medicines (Table 2E) ..............................................................13

Summary for ABC Analysis for All Consumed Medicines (Table 3A1) .........................................17

Class A Items for ABC Analysis of All Consumed Medicines (Table 3A2) .....................................18

Summary of ABC Analysis for HMIS Indicator Medicines (Table 3B1) .........................................21

ABC Analysis for All HMIS Indicator Medicines (Table 3B2) ........................................................22

Quarterly Public Expenditures on Medicines per Patient/Client (Table 4A)................................30

Quarterly Public Expenditures on Medicines per Capita (Table 4B) ...........................................32

Average HF Days of Stock-out for Each Medicine (Table 5A)......................................................34

The Summary of the Overall Volume Indicators for HMIS Indicator Medicines (Table 6) ...........45

II

Acronyms

BDN Bakhtar Development Network

BPHS Basic Package of Health Services

CAF Care of Afghan Families

CPDS Coordinated Procurement and Distribution System

DIC Data and Information Committee

EPHS Essential Package of Hospital Services

GCMU Grant Contract Management Unit

GDPA General Directorate for Pharmaceutical Affairs

HF Health facility

HMIR Hospital Monthly Inpatient Report

HMIS Health Management Information System

HN-TPO Health Net Trans-Cultural Psychosocial Organization

M&E Monitoring and Evaluation

MIAR Monthly Integrated Activity Report

MoPH Ministry of Public Health

MSH Management Sciences for Health

NGO Nongovernmental Organization

PCH Partnership Contracts for Health

PLIS Pharmaceutical Logistics Information System

PMIS Pharmaceutical management information system

RMNCH Reproductive, maternal, newborn and child health

SCA Swedish Committee for Afghanistan

SCD Supply Chain Development

SPS Strengthening Pharmaceutical Systems

USAID US Agency for International Development

III

Acknowledgments

The MoPH would like to express its appreciation to the following professionals for their

contribution and technical support to the PLIS and generating of PLIS quarterly reports:

Pharm. Nazir Ahmad Ahmadzad Planning Manager of Planning Dept. MoPH/GDPA

Dr. Ajmal Yadgari CPDS Technical Coordinator MoPH/GDPA

Syed Asmatullah Fatimi PLIS Consultant MoPH/GDPA

Ajmal Sediqi PLIS Consultant MoPH/GDPA

Pharm. Nanyali Gulistani Planning Dept. MoPH/GDPA

Pharm. Homa Musawi Planning Dept. MoPH/GDPA

Pharm. Sayed Hassan Planning Dept. MoPH/GDPA

Pharm. Khalil Veijah Planning Dept. MoPH/GDPA

Pharm. Zakiullah Azizi Planning Dept. MoPH/GDPA

Jamshid Sabiri HMIS Specialist MoPH

Dr. Zmary Saleh Pharmacy Manager BDN

Pharm. Hashmatullah Hayat Pharmacy Officer CAF

Pharm. Khalil-ur-Rahman Pharmacy Procurement Manager HN-TPO

Dr. Khalil Jibran Senior BPHS Officer SCA

Hafizullah Mahmoodi M&E/PMIS Advisor SPS

Dr. Najia Dehzad SCD Advisor SPS

Dr. Mohammad Osman Zaki Technical Officer SPS

Ahmad Seyar Samadi Database Developer SPS

Dr. Sara Habibyar PMIS Program Manager SPS

Dr. Fahima Noori Technical Officer SPS

Dr. Paul Ickx Senior Principal Technical Advisor SPS

Ms. Shiou-Chu Judy Wang Senior Technical Advisor SPS

Mohammad Zafar Omari Chief of Party, SPS/Afghanistan

Kwesi Eghan Portfolio Manager, SPS

Norio Kasahara Deputy Chief of Party, SPS/Afghanistan

Special thanks also go to all the participating BPHS/EPHS implementers for their cooperation

and support. The PLIS quarterly reports would not be possible without the full and active

participation of these implementers.

The MoPH is also grateful for the generous financial support from the US Agency for

International Development (USAID).

IV

Background

Afghanistan’s Ministry of Public Health (MoPH) has contracted out the implementation of

Basic Package of Health Services (BPHS) and the Essential Package of Hospital Services

(EPHS) services to national or international nongovernmental organizations (NGOs) with the

financial support of international donors since 2005. These implementer NGOs provide

pharmaceutical supplies to their catchment provinces and produced customized

pharmaceutical logistics reports for their own use. However, a system to coordinate and

gather the pharmaceutical supply information in the public sector has been lacking, and the

MoPH did not have information regarding procurement, distribution and consumption of

medicine of the BPHS/EPHS implementer NGOs. The MoPH identified this gap and included

the establishment of pharmaceutical management information system (PMIS) in its Health

Information System Strategic Plan (GOA, 2009).

In order to coordinate the services provided by the BPHS/EPHS implementer NGOs, the

MoPH established the Coordinated Procurement and Distribution System (CPDS) in 2010

(GOA/MoPH, 2010). To address the lack of pharmaceutical supply information, a Data and

Information Committee (DIC) of the CPDS was established and tasked to develop a

Pharmaceutical Logistics Information System (PLIS) to gather the information about

pharmaceutical procurement, distribution and consumption in the BPHS/EPHS

implementers and health facilities. With the support of Strengthening Pharmaceutical

Systems (SPS) program, the DIC developed a PLIS quarterly reporting form and data analysis

system in a Microsoft Excel application, its user manual, macro (value1) and micro (volume2)

indicators. The objectives of the PLIS are to inform the value and volume of the medicines

that flow through the supply chain in the BPHS/EPHS implementers between

central/provincial stores and health facilities; to analyze the consumption pattern; to

redistribute the medicines that are near to expire; and to further forecast the need of the

medicines and the budget.

The PLIS was initially tested with eight BPHS/EPHS implementers in September

2012. It was followed by revising the reporting form and testing with all

BPHS/EPHS implementer NGOs in September 2013. After improving the system,

which includes developing a Microsoft Access database, the PLIS was approved by

MoPH and officially launched on January 05, 2015. Since then, all BPHS/EPHS

implementer NGOs are required to submit their PLIS quarterly reports to the

GDPA/MoPH.

1 “Value” refers to the direct monetary value of the products [sum of (unit price*quantity)]. It does not include other handling or administrative costs. 2 “Volume” refers to the quantities of the products in their administering units (such as tablets, capsules, vials, etc.) or packing unit (such as bottles of any liquid products, or tubes of any cream/ointment etc. with indicated volumes in the medicine list).

1

Executive Summary

The PLIS presents the information in the following categories:

Reporting rates and reporting implementers: Table 1A and 1B

Value indicators for overall transactions: Table 2A, 2B, Figures 1-3

Value indicators for the consumption of HMIS indicator medicines and RMNCH

medicines: Table 2C (MIAR), 2D (HMIR), and 2E (RMNCH)

ABC analysis for total consumed medicines: Table 3A1 and 3A2

ABC analysis for the consumption of HMIS indicator medicines: Table 3B1 and 3B2

Quarterly public expenditure on medicines per patient/client and per capita at the

BPHS/EPHS level: Table 4A and 4B

Average days of stock-out of medicines among health facilities: Table 5A

Summary of volume indicators for overall transactions for HMIS indicator medicines:

Table 6

Highlights for This Reporting Quarter

In this reporting quarter, 21 BPHS/EPHS implementer NGOs were contracted by MoPH. With

the cooperation of these implementers, the reporting rates were 75%, 87%, and 89% for

central, provincial stores, and health facilities (HFs), respectively.

The summary of the values of medicines are as follows.

Overall value indicators:

Total value of the available medicines at the beginning of quarter was US$

6,891,928.15

Total value of medicines purchased and received through donation during the

quarter was US$ 1,792,023.23

Total value of consumed medicine for the reporting quarter was US$ 3,968,759.44.

(See ABC analysis below).

Total reported wastage of medicine was US$ 38,766.05.

Total value of reported ending stock was US$ 6,507,219.55.

ABC analysis3 for the total consumed value (US$ 33,968,759.44):

3 ABC analysis: A method by which medicines are classified as Pareto category A, B, or C according to the monetary value of their usage (unit cost multiplied by consumption volume). The class 'A' items typically account for a large proportion of the overall value with a small percentage of number of items. In the business management, they are the priority items to be managed or controlled.

2

Only 11.43% (59 items) of the medicines accounted for 80% (US$ 3,170,431) of the

total consumed value. These are classified as Class A items and are the priority

medicines to be managed and monitored closely.

14.34% (74 items) of the medicines accounted for 15% (US$ 598,883) of the total

consumed value: Class B items.

74.22% (383 items) of the medicines accounted for only 5% (US$ 199,446) of the

total consumed value: Class C items.

Amoxicillin 500mg cap accounted for the highest consumed value (US$ 293,377.38),

followed by amoxicilin 250mg cap (US$ 175,119.04) and co-trimoxazole 480mg tab

(US$ 170,066.91).

HMIS indicator medicines:

There were 102 items of medicines in the MIAR and 41 items in HMIR reported this

quarter.

ABC analysis: only 17.65% (24 items) of the medicines accounted for 79% (US$

1,952,548) of the total HMIS medicines’ cost (US$ 3,968,759.44).

The top 3 consumed HMIS indicator medicines based on their consumption

quantities are:

1. Paracetamol 500mg tab: 22,561,537 tabs (US$ 133,470.95)

2. Multivitamin Tab: 14,000,546 tabs (US$ 84,730.33)

3. Sulfamethoxazole 400mg+Trimethoprim 80mg tab (Co-trimoxazole):

12,875,219 tabs (US$ 170,066.91)

Reproductive, maternal, newborn and child health (RMNCH) indicator medicines:

There were 95 RMNCH medicines reported this quarter.

The total value of consumed RMNCH medicines was US$ 2,166,612.42. Since some

of these medicines are widely used for other health conditions, this value is based on

the grand total consumption for all treatments. It is not specific for the use in

RMNCH.

Quarterly public expenditure on medicines at the BPHS/EPHS level:

In this quarter, the public expenditure on medicines per patient/client was between

US$ 0.05 and US$ 0.81 in the provinces, with the overall average of US$ 0.31.

The public expenditure on medicines per capita at the BPHS/EPHS level was between

US$ 0.02 and US$ 0.51 in the provinces, with the overall average of US$ 0.21.

Table 1A. Reporting Rates

1Quarter , 1395 (Hamal - Jawza)

Levels Central Provincial HF

This table shows the reporting rates for each level. The PLIS reports are submitted based on theprovinces with which the BPHS/EPHS implementers are working. Only four implementers have central warehouses, of which three submitted their reports (75% reports are received). The number of expected reports from the provincial level is 39, of which 34 reports are received (87%). This table also indicates that the number of expected combined reports from health facility level is 47, of which 42 reports are received (89%).

Number of Reports Expected 4 39 47

Number of Reports Submitted 3 34 42

Reporting Rate 75% 87% 89%

Combined HF report: The report in the HF level is a combination of reports from all health facilities in that province under the management of the contracted implementer. 3

Table 1B. Reporting Details by Provinces and NGOs


This table shows the reporting details of each NGO with the details of their reporting level and the provinces with which they are working.

HFsProvincialCentralProvincesNGOs Status

YesYesN/AFaryabAADA C

NoNoN/AKhostAADA NC

YesYesN/ANangarharAADA C

YesYesN/ASamanganAADA C

YesYesN/ATakharAADA C

YesYesN/AGhorACTD C

YesYesN/AHelmandACTD C

YesYesN/AUrozganAHDS C

YesN/AN/ABadakhshanAKHS C

YesN/AN/ABamyanAKHS C

YesYesN/ABamyanBARAN C

YesYesN/AKandaharBARAN C

YesYesN/ABaghlanBDN C

YesYesN/ABalkhBDN C

YesN/AN/AGhazniBDN C

YesYesN/AHiratBDN C

YesYesN/ASar-e-PulBDN C

YesYesN/ABadakhshanCAF C

YesN/AN/ADykundiCAF C

YesYesN/ALogarCAF C

YesYesN/AFarahCHA C

YesYesN/AZabulHADAAF C

YesYesN/ANangarharHNTPO C

NoYesN/APaktyaHNTPO NC

YesYesN/ANooristanIMC C

YesYesN/APaktikaIMC C

- C= Completed (All the required reports were submitted), NC= Not Completed (Not all the required reports were submitted), NA= Not Applicable (Don’t have service at this level)

4

HFsProvincialCentralProvincesNGOs Status

YesYesN/AGhazniMMRC-A C

YesYesN/ABadghisMOVE C

YesYesN/ABamyanMOVE C

YesYesN/AKabulMOVE C

YesN/AN/ANimrozMOVE C

YesN/AN/AFarahMRCA C

YesN/AYesLogarMRCA C

YesYesN/APaktyaMRCA C

YesYesN/AKhostOHPM C

YesYesN/APaktikaOHPM C

YesYesN/AGhazniORCD C

YesYesN/ADykundiPU-AMI C

YesYesYesKunarPU-AMI C

YesYesN/AJawzjanSAF C

YesYesN/ANimrozSAF C

N/AN/ANoKabulSCA NC

YesNoN/ALaghmanSCA NC

YesN/AN/AWardakSCA C

YesYesYesKunduzSCI C

NoNoN/AKapisaSM NC

NoNoN/APanjsherSM NC

NoNoN/AParwanSM NC

- C= Completed (All the required reports were submitted), NC= Not Completed (Not all the required reports were submitted), NA= Not Applicable (Don’t have service at this level)

5

Table 2A. The Summary of Overall Value Indicators


Beginning Stock

Total Value of Purchased and Donation during the Quarter

Total Value of Received from Central/Provincial levels during the Quarter

Total Consumed

Reported Wastage

Reported Ending Stock

Inddicators

This table summarizes the overall value of the reported medicines flowing between central, provincialand health facilities. There was US$ 6,891,928.15 of the medicines at the beginning of the quarter, withthe addition of purchases and donations during the quarter worth US$ 1,792,023.23. The grand totalconsumed value for this quarter was US$ 3,968,759.44, this table also shows that the total wastage wasUS$ 38,766.05, and total remaining medicines’ value at the end of quarter was US$ 6,507,219.55.

Value in US$

6,891,928.15

1,792,023.23

5,097,683.66

3,968,759.44

38,766.05

6,507,219.55

Beginning Stock

The stock on hand at the beginning of the quarter in all the central and provincial stores and HFs (same as the ending stock reported in the previous quarter)

Total Value of Received from Central/Provincial

Reflect the sum-up value in both provincial and health facility levels. It may include the vlaue that is received at the provincial level, and some of them distributed to health facility level, which may have double count in the "Grand Total" value.

Total Value of Purchased and Donation during the quarter

Reflect the total Medicine Purchased in Central and Provincial levels plus total Donation received in all levels during the quarter

Reported wastage

The total wastage due to expiration or damage reported by all central and provincial stores and HFs

Reported Ending stock

The stock on hand reported by all the central and all central and provincial stores and HFs 6

Table 2B. The Summary of Value Indicators by Levels1Quarter , 1395 (Hamal - Jawza)

This table indicates the breakdown of the information shown in Table 2A at each level (central, provincial and health facilities).

Value in US$

Reported total value remained at the end of the quarter

Total value of wastage

Total value of the medicines consumed

Total value of the medicines donated out

Total value of the medicines distributed

Total Value of Recived Medicines from Central/Provincial levels

Total Value of Purchased and Donation during the Quarter

Total Value of Beginning Stock

Grand TotalHFsProvincialCentral

6,891,928.07270,041.39 2,382,072.32 4,239,814.36

1,792,023.24313,578.32 1,407,056.41 71,388.51

5,097,683.750.00 1,480,127.42 3,617,556.33

3,286,373.29199,504.95 3,086,868.34 0.00

19,620.347.29 19,613.05 0.00

3,968,759.190.00 0.00 3,968,759.19

38,765.99439.08 12,060.78 26,266.13

6,507,219.45383,668.52 2,171,858.31 3,951,692.62

Total Value of Recived Medicines from Central/Provincial levels:

Reflect the sum-up value in both provincial and health facility levels. It may include the vlaue that is received at the provincial level, and some of them distributed to health facility level, which may have double count in the "Grand Total" value.

Total Value of Purchased and Donation during the quarter

Reflect the total Medicine Purchased in Central and Provincial levels plus total Donation received in all levels during the quarter

7


Figure 1

Figure 1: Total Value and Sources of Received Medicines at the Central Level (Value in US$)

48%0%

52%0%

International Purchase

Direct Donation

National Purchase

From Donors

This figure displays the total value and sources of medicine at the central level.It indicates that the medicines were received from four sources: direct donation, international purchase, local purchase and from donors. Most of the medicines were received from local purchases (US$ 162,949.39: 52%), followed by international purchases (US$ 150,621.68; 48%) and direct donation has very less amount which is reported.

International Purchase Direct Donation National Purchase From Donors Total

150,621.68 7.29 162,949.39 0.00 313,578.36

8


Figure 2: Total Value and Sources of Received Medicines at the Provincial Level (Value in US$)

0%

47%

2%

51%

0%

International Purchase

National Purchase

From Donors

Direct Donation

Received from Central

This figure shows the total value and sources of medicine at the provincial level. It indicates that the medicines were received from five sources: direct donation, international purchase, local purchase, from donors via international purchase, and from central stores. Most of the medicines were received from central stores (US$ 1,480,127.33: 51%),followed by national purchases (US$ 1,355,088.30: 47%), followed by direct donation (US$ 45,343.25; 2%), followed by international purchases (US$ 3,637.80: 0,13%) and only (US$ 2,987.02: 0.11%) was received by donors' international purchases.

International Purchase National Purchase From Donors Direct Donation Received Central Total

3,637.80 1,355,088.30 2,987.02 45,343.25 1,480,127.33 2,887,183.70

9


Figure 3: Total value of Medicines available and consumed at the HFs level (Value in US$)

0

500000

1000000

1500000

2000000

2500000

3000000

3500000

4000000

4500000

Value at the Beginning Value Received Donation Value Consumed Value at the end

This figure indicates the total value of medicine available and consumed at the HF level. Total value of medicine at the beginning of the quarter in all HFs was US$ 4,239,814.36 and total value of medicine received from central or provincial levels was US$ 3,617,556.33; the value of the received donation was US$ 71,388.51. The total consumption of medicines in all HFs was US$ 3,968,759.19, the value of the medicines remaining at the end of the quarter was US$ 3,951,692.62.

Value at the Beginning Value Received Donation Value Consumed Value at the end

4,239,814.36 3,617,556.33 71,388.51 3,968,759.19 3,951,692.62

10

Table 2C. The Consumed Value of HMIS Indicator Medicines for MIAR


The HMIS indicator medicines include those for priority health conditions such as RMNCH, infectious diseases,tuberculosis and malaria, cardiovascular diseases, psychotropic disorders, pain and fever, electrolyte or nutritional supplements, etc. This table shows the consumed value of each category and grand total of the MIAR medicines.

M# MIAR Indicator Medicines No. of Items Consumed Value in US$

M1 Acetyl Salicylic Acid/ Paracetamol 9 290,843.48

M2 Mebandazole 2 13,374.76

M3 Amoxicilin/Ampicillin 7 694,562.06

M4 INH 2 1,158.58

M5 Rifampicin 5 14,663.21

M6 Amp. Diazepam 1 4,950.26

M7 Inj. Lidocaine 7 7,199.82

M8 Metronidazole 10 223,645.83

M9 Co-trimoxazole 4 289,855.82

M10 Anti-hypertensives 19 79,748.00

M11 Oral contraceptive 6 53,476.01

M12 Injectable contraceptive 1 41,136.85

M13 Condoms 1 31,486.54

M14 ORS 2 153,718.32

M15 Zinc tablets 2 45,370.95

M16 Vitamin A 4 48,418.82

M17 Ferrous Sulfate + folic acid 4 112,860.67

M18 Oxytocin 1 13,954.23

M19 Chloroquine 6 12,119.13

M20 Artesunate + SP 5 8,998.13

M21 Amitriptiline/ Fluoxetine 4 23,971.78

Grand Total 102 2,165,513.25

11

Table 2D. The Consumed Value of HMIS Indicator Medicines for HMIR


This table shows the consumed value of each category and grand total of the HMIR medicines.

H# HMIR Indicator Medicines No. of Items Consumed Value in US$

H1 ACT 5 8,998.13

H2 Atropine inj 3 884.97

H3 Benzyl Penicilline inj 2 3,840.82

H4 Digoxin 2 106.49

H5 Ergometrine inj 4 8,496.91

H6 Furosemide inj 1 1,588.46

H7 Gentamicin inj 3 36,323.35

H8 Iodine povidone 1 19,596.32

H9 Ketamin inj 1 12,770.22

H10 Lidocaine 5% spinal inj 1 504.88

H11 Magnesium Sulphate 2 2,002.34

H12 Morphine inj 1 13,202.53

H13 Naloxone inj 1 1,777.77

H14 Hydralazine inj 1 1,780.45

H15 Pethidine inj 2 154.54

H16 Phenobarbital inj 3 1,436.99

H17 Quinine inj 1 1,109.69

H18 Ranitidine inj 1 888.42

H19 Ringer lactate IV 2 132,307.44

H20 Salbutamol inj 2 2,462.91

H21 Sodium chloride IV 2 76,112.88

Grand Total 41 326,346.51

12

This table shows the consumption value of RMNCH indicator medicines. In total, RMNCH medicines were reported. The total value of consumed RMNCH medicines was US$

95

Table 2E. The Consumed Value of RMNCH Medicines


2,166,612.42

RMNCH Medicines Consumed Value in US$

Acetylsalicylic acid (Aspirin) 100mg tab 3,330.13

Amoxicillin 125mg + Clavulanic acid 31.25mg/5ml, in 60ml bottle, Susp 1,997.48

Amoxicillin 125mg/5ml, in 60ml bottle, susp 41,826.84

Amoxicillin 250mg Cap 175,119.04

Amoxicillin 250mg/5ml, in 60ml bottle, Susp 66,313.49

Amoxicillin 500mg Cap 293,377.38

Amoxicillin 500mg+Clavulanic acid 125mg (Co-amoxiclav) Tab 747.92

Ampicillin 1g vial 71,177.29

Ampicillin 500mg Tab 1,895.86

Ampicillin 500mg vial 44,852.16

Calcium 250mg Tab 85.38

Calcium Gluconate 10% 10ml Amp 692.39

Chloroquine 100mg Tab 0.00

Chloroquine 150mg Tab 6,252.51

Chloroquine 50mg/5ml 60ml Syr 5,524.22

Condom 31,486.54

Dexamethasone 4mg /ml 1ml Amp 222.30

Ergometrine 0.2mg Tab 6,338.45

Ergometrine 0.2mg/ml, 1ml Amp 2,058.37

Erythromycin (Base) 125mg/5ml, in 60ml, susp 5,050.32

Erythromycin (Base) 200mg/5ml, in 60ml, susp 34,765.15

Erythromycin (Ethyl Succinate) 100mg/ml 100ml Susp 7,823.78

-Essential Interventions, Commodities and Guideline for Reproductive, Maternal, Newborn and Child Health WHO.

Note: The consumption of these medicines is not only for RMNCH, but also for other health conditions. The consumed values indicate the overall usage of these medicines in the reporting quarter.

The RMNCH Medicine List has been taken from below references:

13


Erythromycin Stearate 250mg Tab 7,319.03

Erythromycin Stearate 500mg Tab 4,934.25

Ethinylestradiol 0.035mg+Norethisterone 1mg Cycle 2,520.10

Ethinylestradiol 0.03mg+Levonorgestrel 0.15mg Cycle 46,108.70

Ethinylestradiol 0.03mg+Norgestrel 0.3mg Cycle 616.36

Ethinylestradiol 0.05mg+Levonorgestrel 0.25mg Cycle 5.83

Ferrous sulfate 125mg/5ml, in 120ml , oral liquid 1,688.45

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.25mg Tab 40,973.64

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.4mg Tab 27,574.59

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.5mg Tab 719.06

Ferrous Sulfate 25mg/ml 120ml Drop 8,814.06

Ferrous Sulfate 60mg Tab 3,199.20

Ferrous Sulfate 75mg/0.6ml 10ml Drop 416.02

Ferrous Sulphate 200mg Tab 3,731.89

Ferrous Sulphate 60mg+Folic Acid 0.4mg Tab 43,593.39

Folic Acid 1mg Tab 1,469.35

Folic Acid 5mg Tab 7,276.03

Gentamicin 10mg/ml, 2ml Amp 6,994.64



Hydralazine 20mg/ml, in 2ml , Amp 1,780.45

Hydralazine 25mg Tab 0.00

Hydralazine 50mg Tab 69.21

Hydroxocobalamine (Vit B12) 1mg/ml, in 1ml Amp 13.12

Intrauterine device (IUD) with copper 1pce , vaginal intra uterine device 1,764.71

Magnesium Sulfate 500mg/ml (50%) 10ml Amp 1,343.15

Magnesium Sulfate 500mg/ml (50%) 20ml Amp 659.19




14


Medroxyprogesterone acetate Depot 150mg/ml, in 1ml vial 41,136.85

Methyldopa 250mg Tab 57,222.56

Methylergometrine 0.125mg Tab 86.36

Methylergometrine 0.2mg Tab 0.00

Methylergometrine 0.2mg/ml, 1ml Amp 13.73

Metronidazole 120mg/5ml, in 100ml bottle, Susp 6,262.24

Metronidazole 200mg Tab 47,278.11

Metronidazole 200mg/5ml, in 100ml bottle, Susp 51,449.05

Metronidazole 250mg Tab 340.89

Metronidazole 400mg Tab 59,560.70

Metronidazole 500mg Tab 340.83

Metronidazole 5mg/ml, in 100ml bottle, infusion Sol 28,545.86

Misoprostol 200mcg Tab 443.24

Nifedipine 10mg Tab/Cap 3,452.93

Nifedipine 20mg Tab/Cap 466.77

Norethindrone 0.35mg (Progestin-Only Pills or Mini-Pills) 0.00

Norgestrel 0.03mg Cycle 45.66

Norgestrel 0.075mg Cycle 4,179.37

Oral rehydration salts (ORS , Resomal and low osmolar) 20.5g/Lit 99,901.24

Oral rehydration salts (ORS , Resomal and low osmolar) 27.9g/Lit 53,817.08

Oxytocine 10IU/ml in 1ml Amp 13,954.23

Paracetamol (Acetaminophen) 225mg/3ml, Amp (75mg/ml) 0.00

Paracetamol 100mg Tab 38,747.95

Paracetamol 100mg/ml, 15ml Drop 79.03

Paracetamol 120mg/5ml, 60ml Syr 68,068.57

Paracetamol 325mg Tab 99.32

Paracetamol 500mg Tab 133,470.92




15


Penicillin Benzyl (Peni G crystal) 1MU Vial 350.05

Penicillin Benzyl (Peni G crystal) 5MU Vial 3,490.77

Penicillin Benzyl Benzathine 1.2MU Vial 4,413.71

Penicillin Benzyl Benzathine 2.4MU Vial 9,770.63

Penicillin Benzyl Procaine 1MU Vial 0.00

Penicillin Benzyl Procaine 2MU Vial 6,143.07



Penicillin Benzyl Procaine 800,000U Vial 107.60

Retinol (Vit A) 100,000 IU Amp 0.00

Retinol (Vit A) 100,000 IU Tab 7,181.39

Retinol (Vit A) 200,000 IU Cap 32,158.98

Retinol (Vit A) 50,000IU Cap 9,078.45

Sulfamethoxazole 100mg+Trimethoprim 20mg Tab (Co-trimoxazole) 66,203.33

Sulfamethoxazole 200mg+Trimethoprim 40mg/5ml 50ml Susp (Co-trimoxa 52,835.31

Sulfamethoxazole 400mg+Trimethoprim 80mg 50ml Susp (Co-trimoxazole) 750.28

Sulfamethoxazole 400mg+Trimethoprim 80mg Tab (Co-trimoxazole) 170,066.91

Zinc Sulfate 10mg Tab 0.00

Zinc Sulfate 20mg Tab 45,370.95

Grand Total 2,166,612.42




16

Class % Of Consumed Value in US$

Number of Medicines Consumed Value in US$

% Of Medicines

Table 3A1. Summary for ABC Analysis for All Consumed Medicines


This table shows the summary of ABC analysis for the overall consumption, which reveals that only 11.43% (59 items) of the medicines accounted for 80% (US$ 3,170,431) of the total consumed value (class A items); 14.34% of medicines (74 items) accounted for 15% (US$ 598,883) of the total consumed value (class B items); and 74.22% (383 items) of the medicines accounted for only 5% (US$ 199,446) of the total consumed value (class C items).This information indicates that the 59 class A items should be closely monitored and managed as they cost most. The next table (table 3A2) will provide details of the class A medicines.

A 80 59 3,170,43111.43

B 15 74 598,88314.34

C 5 383 199,44674.22

Total 100 516 3,968,759100.00

17

Table 3A2. Class A Items for ABC Analysis of All Consumed Medicines1Quarter , 1395 (Hamal - Jawza)

This table shows the medicines that cost most (class A items) from ABC analysis by the order of their consumed value (The unit prices are rounded to two decimals). It is to highlight the small portion of the medicines which accounted for majority of the cost. They are the priority medicines that need to be managed and monitored closely. For example, amoxicillin 500mg cap alone accounted for 7.39% (US$ 293,377.38) of the total consumed value. It is followed by amoxicilin 250mg cap for 4.41% (US$ 175,119.04), and co-trimoxazole 480mg tablets for 4.55% (US$ 170,066.91) of the total cost. These three medicines were ranked as the top three consumed medicines of the overall consumption in value.

Medicines HMIS Code Total Consumed Value at all HFs in US$

Total Consumed Quantity

Average Unit Pricein US$

% of the Value % of Cumulative Value

Class

Amoxicillin 500mg Cap 293,377.38 9,709,950 0.0320 7.39 7.39 AM3


Sulfamethoxazole 400mg+Trimethoprim 80mg Tab (Co-trimoxazole)

170,066.91 12,875,219 0.0126 4.29 16.09 AM9

Paracetamol 500mg Tab 133,470.95 22,561,537 0.0062 3.36 19.45 AM1

Ringer lactate 1000ml IV infusion 107,110.71 154,397 0.7064 2.70 22.15 AH19

Oral rehydration salts (ORS , Resomal and low osmolar) 20.5g/Lit

99,901.26 1,742,326 0.0559 2.52 24.67 AM14

Multivitamin Tab 84,730.33 14,000,546 0.0059 2.13 26.80 A

Ampicillin 1g vial 71,177.33 323,314 0.2286 1.79 28.60 AM3

Penicillin V Potassium 500mg Tab 71,091.44 2,273,563 0.0305 1.79 30.39 A

Sodium Chloride 0.9% 1000ml IV infusion (Normal Saline)

70,167.27 114,040 0.6276 1.77 32.16 AH21

Paracetamol 120mg/5ml, 60ml Syr 68,068.60 250,176 0.2933 1.72 33.87 AM1

Amoxicillin 250mg/5ml, in 60ml bottle, Susp 66,313.48 161,487 0.4170 1.67 35.54 AM3


66,203.34 6,349,531 0.0098 1.67 37.21 AM9

Metronidazole 400mg Tab 59,560.70 4,847,588 0.0119 1.50 38.71 AM8

Penicillin V(Phenoxy methyl Penicillin) 250mg/5ml, in 100ml bottle, Susp

57,726.63 76,926 0.7131 1.45 40.17 A

Methyldopa 250mg Tab 57,222.56 1,587,793 0.0380 1.44 41.61 AM10


53,817.06 930,228 0.0455 1.36 42.96 AM14 18





Class

Sulfamethoxazole 200mg+Trimethoprim 40mg/5ml 50ml Susp (Co-trimoxazole)

52,835.28 208,209 0.2396 1.33 44.29 AM9

Metronidazole 200mg/5ml, in 100ml bottle, Susp

51,449.05 155,108 0.3085 1.30 45.59 AM8

Penicillin V Potassium 250mg Tab 49,900.98 1,985,930 0.0227 1.26 46.85 A

Ibuprofen 200mg Tab 47,507.85 6,370,449 0.0077 1.20 48.05 A


Acetylsalicylic acid (Aspirin) 500mg tab 46,519.94 4,857,806 0.0084 1.17 50.41 AM1

Ethinylestradiol 0.03mg+Levonorgestrel 0.15mg Cycle

46,108.69 344,514 0.1310 1.16 51.57 AM11

Zinc Sulfate 20mg Tab 45,370.98 3,005,656 0.0191 1.14 52.71 AM15

Ampicillin 500mg vial 44,852.14 274,868 0.1670 1.13 53.84 AM3

Ferrous Sulphate 60mg+Folic Acid 0.4mg Tab 43,593.37 6,643,301 0.0046 1.10 54.94 AM17

Amoxicillin 125mg/5ml, in 60ml bottle, susp 41,826.83 96,904 0.4072 1.05 56.00 AM3

Medroxyprogesterone acetate Depot 150mg/ml, in 1ml vial

41,136.85 130,319 0.2843 1.04 57.03 AM12

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.25mg Tab

40,973.64 9,826,426 0.0041 1.03 58.07 AM17

Methylrosaniline (Gentian Violet) 25g Powder

40,832.00 51,594 0.6356 1.03 59.09 A

Aluminium hydroxide 200mg+Magnesium hydroxide 200mg tab

40,807.71 8,287,593 0.0056 1.03 60.12 A

Chloramphenicol 250mg Cap 39,536.14 1,670,934 0.0235 1.00 61.12 A


Ceftriaxone 1g Vial 38,204.50 69,202 0.5195 0.96 63.06 A

Tetracycline Eye 1% Oint 37,605.07 325,096 0.1136 0.95 64.01 A

Ciprofloxacin 250mg Tab 36,711.67 1,132,770 0.0290 0.93 64.93 A

Chloramphenicol 1g Vial 34,815.18 85,429 0.3824 0.88 65.81 A

Erythromycin (Base) 200mg/5ml, in 60ml, susp

34,765.15 66,832 0.5180 0.88 66.68 A19





Class

Retinol (Vit A) 200,000 IU Cap 32,159.03 852,603 0.0353 0.81 67.49 AM16

Condom 31,486.53 1,786,290 0.0179 0.79 68.29 AM13

Ceftriaxone 500mg Vial 31,304.25 64,256 0.4358 0.79 69.08 A

Doxycycline 100mg Cap 29,303.37 1,938,271 0.0156 0.74 69.81 A

Salbutamol 0.1mg/dose 200 dose Bottle Inhalation Sol

29,295.26 17,312 1.6609 0.74 70.55 A

Chloramphenicol 125mg/5ml 100ml Bottle Susp

28,765.38 67,602 0.4074 0.72 71.28 A

Metronidazole 5mg/ml, in 100ml bottle, infusion Sol

28,545.86 70,704 0.4088 0.72 72.00 AM8

Glucose 5% 1000ml IV infusion 28,342.87 41,282 0.6334 0.71 72.71 A


27,574.59 4,015,370 0.0082 0.69 73.41 AM17

Silver Sulfadiazine 1% Oint 26,523.26 43,930 0.5504 0.67 74.07 A


Aluminium hydroxide 500mg tab 24,260.05 4,016,793 0.0053 0.61 75.32 A

Ibuprofen 400 mg Tab 24,221.13 1,653,184 0.0143 0.61 75.93 A

Aluminium hydroxide 225mg+Magnesium hydroxide 200mg/5ml, 200ml/bottle, susp

23,991.47 76,744 0.2742 0.60 76.53 A

Glucose 5% 500ml IV infusion 23,644.37 49,524 0.4384 0.60 77.13 A

Aluminium hydroxide 120mg+Magnesium trisilicate 250mg tab

22,584.70 3,720,250 0.0039 0.57 77.70 A

Cloxacillin 500mg Cap 22,580.98 524,350 0.0410 0.57 78.27 A

Hydrocortisone Sodium Succinate 100mg Vial

22,330.51 52,703 0.4329 0.56 78.83 A

Gentamicin 40mg/ml, 2ml Amp 22,220.23 167,322 0.1403 0.56 79.39 AH7

Povidone-Iodine 10% Topical Sol 19,596.35 12,092 1.4695 0.49 79.88 AH8

20

Class % Of Consumed Value in US$

Number of Medicines Consumed Value in US$

% Of Medicines

Table 3B1. Summary of ABC Analysis for HMIS Indicator Medicines


This table indicates the summary of ABC analysis for HMIS indicator medicines. It shows that, out of 136 of thetotal HMIS indicator medicines, only 17.65% (24 items) of them accounted for 79% (US$ 1,952,548) of the totalconsumed value (Class A items), 14.71% (20 items) accounted for 16% (US$ 396,490) of the total consumed value(Class B items), and 67.65% (92 items) accounted for only 5% (US$ 130,455) of the total consumed value (Class C items). This information indicates that, among HMIS medicines, these 24 class A items should be closely monitored and managed as they cost most. The next table (Table 3B2) provides details of the ABC analysis by the order of the medicines consumed values.

A 79 24 1,952,54817.65

B 16 20 396,49014.71

C 5 92 130,45567.65

Total 100 136 2,479,493100.00

21

Table 3B2. ABC Analysis for All HMIS Indicator Medicines


This table shows the ABC analysis for all HMIS indicator medicines with details by the order of their consumed value and ABC classes. The HMIS code represents the categories of the medicines (M for MIAR, H for HMIR). (The unit prices are rounded to four decimals). The data indicate that amoxicillin 500mg cap alone accounted for 11.83% (US$ 293,377.38) of the total HMIS medicines’ consumed value. It is followed by amoxicilin 250mg cap for 7.06% (US$ 175,119.04) and cotrimoxazole 480mg tablets which accounted for 6.86% (US$ 170,066.91) of the total HMIS medicines’ consumed value. These three medicines were ranked as top three consumed HMIS indicator medicines in value.

Medicines HMIS Code Total Conumed Value at all HFs in US$




Class




170,066.91 12,875,219 0.0126 6.86 25.75 AM9




99,901.26 1,742,326 0.0559 4.03 39.49 AM14

Ampicillin 1g vial 71,177.33 323,314 0.2286 2.87 42.36 AM3


70,167.27 114,040 0.6276 2.83 45.19 AH21

Paracetamol 120mg/5ml, 60ml Syr 68,068.60 250,176 0.2933 2.75 47.93 AM1

Amoxicillin 250mg/5ml, in 60ml bottle, Susp 66,313.48 161,487 0.4170 2.67 50.61 AM3


66,203.34 6,349,531 0.0098 2.67 53.28 AM9


Methyldopa 250mg Tab 57,222.56 1,587,793 0.0380 2.31 57.99 AM10


53,817.06 930,228 0.0455 2.17 60.16 AM14

22





Class


52,835.28 208,209 0.2396 2.13 62.29 AM9


51,449.05 155,108 0.3085 2.07 64.36 AM8


Acetylsalicylic acid (Aspirin) 500mg tab 46,519.94 4,857,806 0.0084 1.88 68.15 AM1


46,108.69 344,514 0.1310 1.86 70.00 AM11

Zinc Sulfate 20mg Tab 45,370.98 3,005,656 0.0191 1.83 71.83 AM15

Ampicillin 500mg vial 44,852.14 274,868 0.1670 1.81 73.64 AM3

Ferrous Sulphate 60mg+Folic Acid 0.4mg Tab 43,593.37 6,643,301 0.0046 1.76 75.40 AM17

Amoxicillin 125mg/5ml, in 60ml bottle, susp 41,826.83 96,904 0.4072 1.69 77.09 AM3


41,136.85 130,319 0.2843 1.66 78.75 AM12


40,973.64 9,826,426 0.0041 1.65 80.40 BM17

Paracetamol 100mg Tab 38,747.94 9,480,534 0.0039 1.56 81.96 BM1

Retinol (Vit A) 200,000 IU Cap 32,159.03 852,603 0.0353 1.30 83.26 BM16

Condom 31,486.53 1,786,290 0.0179 1.27 84.53 BM13

Metronidazole 5mg/ml, in 100ml bottle, infusion Sol

28,545.86 70,704 0.4088 1.15 85.68 BM8


27,574.59 4,015,370 0.0082 1.11 86.79 BM17

Ringer lactate 500ml IV infusion 25,196.74 49,922 0.4420 1.02 87.81 BH19

23





Class

Gentamicin 40mg/ml, 2ml Amp 22,220.23 167,322 0.1403 0.90 88.71 BH7

Povidone-Iodine 10% Topical Sol 19,596.35 12,092 1.4695 0.79 89.50 BH8


17,482.68 40,550 0.3882 0.71 90.20 BM8

Fluoxetine 20mg Cap 14,260.67 869,574 0.0251 0.58 90.78 BM21

Oxytocine 10IU/ml in 1ml Amp 13,954.21 241,226 0.0594 0.56 91.34 BM18

Mebendazole 100mg Tab 13,374.75 1,676,672 0.0084 0.54 91.88 BM2

Morphine (sulfate,hydrochloride) 10mg/ml, in 1ml Amp

13,202.52 3,049 3.0338 0.53 92.41 BH12

Ketamin 50mg/ml 10ml Vial 12,770.22 5,805 2.1078 0.52 92.93 BH9


11,670.95 37,547 0.2490 0.47 93.40 BM8

Amitriptylline 25mg tab 9,493.25 1,018,006 0.0093 0.38 93.78 BM21

Retinol (Vit A) 50,000IU Cap 9,078.46 221,465 0.0198 0.37 94.15 BM16

Rifampicin 150mg+Isoniazid 75mg+Pyrazinamide 400mg+Ethambutol 275mg (RHZE) per Tab

7,519.68 151,329 0.0215 0.30 94.45 BM5

Retinol (Vit A) 100,000 IU Tab 7,181.39 220,900 0.0347 0.29 94.74 BM16

Gentamicin 20mg/ml, 2ml Amp 7,108.50 56,757 0.1160 0.29 95.03 CH7

Gentamicin 10mg/ml, 2ml Amp 6,994.63 69,145 0.0874 0.28 95.31 CH7

Ergometrine 0.2mg Tab 6,338.44 275,231 0.0230 0.26 95.56 CH5


6,262.24 23,382 0.2508 0.25 95.82 CM8

24





Class

Chloroquine 150mg Tab 6,252.52 597,962 0.0104 0.25 96.07 CM19


5,945.59 11,190 0.4790 0.24 96.31 CH21

Chloroquine 50mg/5ml 60ml Syr 5,524.22 18,915 0.3694 0.22 96.53 CM19

Rifampicin 150mg+Isoniazid 75mg (RH) Tab 5,400.85 237,079 0.0078 0.22 96.75 CM5

Atenolol 50mg Tab 5,328.18 411,442 0.0131 0.21 96.96 CM10

Diazepam 5mg/ml 2ml Amp 4,950.28 40,928 0.1817 0.20 97.16 CM6

Lidocaine 2% in 20ml Vial 4,796.78 11,435 0.3605 0.19 97.36 CM7

Hydrochlorothiazide 50mg Tab 4,658.73 611,039 0.0084 0.19 97.54 CM10

Norgestrel 0.075mg Cycle 4,179.36 35,202 0.1112 0.17 97.71 CM11

Penicillin Benzyl (Peni G crystal) 5MU Vial 3,490.77 12,778 0.2301 0.14 97.85 CH3

Nifedipine 10mg Tab/Cap 3,452.94 208,262 0.0227 0.14 97.99 CM10

Artesunate 50mg+Pyrimethamine 25mg+Sulfadoxine 500mg Blister

3,380.12 5,081 0.6119 0.14 98.13 CH1, M20

Acetylsalicylic acid (Aspirin) 100mg tab 3,330.13 475,445 0.0059 0.13 98.26 CM1

Atenolol 100mg Tab 2,910.33 172,141 0.0161 0.12 98.38 CM10

Ethinylestradiol 0.035mg+Norethisterone 1mg Cycle

2,520.10 20,499 0.1140 0.10 98.48 CM11

Artesunate 600mg+Pyrimethamine 75mg+ Sulfadoxine 1500mg Blister

2,405.97 2,180 0.6866 0.10 98.58 CH1, M20

Ergometrine 0.2mg/ml, 1ml Amp 2,058.36 18,974 0.0927 0.08 98.66 CH5

Ampicillin 500mg Tab 1,895.87 29,886 0.0860 0.08 98.74 CM3

25





Class

Salbutamol 0.05mg/ml (50mcg/ml) in 5ml Amp

1,848.72 6,408 0.2461 0.07 98.81 CH20

Hydralazine 20mg/ml, in 2ml , Amp 1,780.45 2,371 0.6487 0.07 98.89 CH14, M10

Naloxone 400mcg/ml (0.4mg/ml) in 1ml Amp

1,777.76 4,804 0.4329 0.07 98.96 CH13

Furosemide 10mg/ml, in 2ml Amp 1,588.47 23,110 0.0609 0.06 99.02 CH6, M10


1,518.59 1,092 0.8210 0.06 99.08 CH1, M20


1,438.44 1,820 0.8001 0.06 99.14 CH1, M20

Magnesium Sulfate 500mg/ml (50%) 10ml Amp

1,343.15 5,984 0.1935 0.05 99.19 CH11

Lidocaine 2% in 2ml Amp 1,290.29 10,901 0.1264 0.05 99.25 CM7

Furosemide 40mg Tab 1,238.70 117,027 0.0112 0.05 99.30 CM10

Isoniazid 100mg Tab (INH) 1,158.59 21,832 0.0169 0.05 99.34 CM4

Rifampicin 150mg+Isoniazid 75mg+Ethambutol 275mg (RHE) Tab

1,139.11 29,163 0.0127 0.05 99.39 CM5

Quinine dihydrochloride 300mg/ml, in 2ml Amp

1,109.70 5,050 0.3179 0.04 99.43 CH17

Phenobarbital 100mg/ml, in 2ml Amp 899.78 2,606 0.3843 0.04 99.47 CH16

Ranitidine 25mg/ml, in 2ml Amp 888.41 7,188 0.1343 0.04 99.51 CH18

Atropine sulfate 1mg/ml, in 1ml Amp 884.98 14,512 0.0853 0.04 99.54 CH2

Sulfamethoxazole 400mg+Trimethoprim 80mg 50ml Susp (Co-trimoxazole)

750.28 100,037 0.0038 0.03 99.57 CM9


719.06 102,750 0.0070 0.03 99.60 CM17

26





Class


714.55 3,483 0.2478 0.03 99.63 CM8

Lidocaine 2% in 50ml Vial 690.43 1,906 0.3620 0.03 99.66 CM7

Magnesium Sulfate 500mg/ml (50%) 20ml Amp

659.17 1,622 0.4131 0.03 99.68 CH11

Ethinylestradiol 0.03mg+Norgestrel 0.3mg Cycle

616.36 10,840 0.0306 0.02 99.71 CM11

Salbutamol 0.5mg/ml, in 1ml Amp 614.20 3,457 0.1586 0.02 99.73 CH20

Acetylsalicylic acid (Aspirin) 300mg tab 527.61 60,560 0.0051 0.02 99.76 CM1

Furosemide 20mg Tab 521.10 47,940 0.0092 0.02 99.78 CM10

Lidocaine 5% 2ml Amp 504.89 2,751 0.1843 0.02 99.80 CH10

Nifedipine 20mg Tab/Cap 466.77 19,278 0.0159 0.02 99.82 CM10

Phenobarbital 200mg/ml, 1ml Amp 462.43 1,140 0.3774 0.02 99.83 CH16

Rifampicin 60mg+Isoniazid 30mg (RH) Tab 408.58 20,315 0.0103 0.02 99.85 CM5

Lidocaine 1% in 2ml Amp 370.28 1,674 0.1836 0.01 99.87 CM7

Penicillin Benzyl (Peni G crystal) 1MU Vial 350.06 2,120 0.1349 0.01 99.88 CH3

Metronidazole 250mg Tab 340.89 48,963 0.0013 0.01 99.91 CM8

Metronidazole 500mg Tab 340.83 38,962 0.0015 0.01 99.91 CM8


255.01 250 0.6676 0.01 99.92 CH1, M20

Propranolol 40mg Tab 216.31 26,937 0.0110 0.01 99.93 CM10

Rifampicin 60mg+Isoniazid 30mg+Pyrazinamide 150mg (RHZ) Tab

195.00 8,290 0.0078 0.01 99.93 CM5

27





Class

Chloroquine Phosphate 300mg Tab 192.07 18,297 0.0052 0.01 99.94 CM19

Captopril 25mg Tab 183.19 10,330 0.0232 0.01 99.95 CM10

Amitriptylline 10mg tab 160.74 24,500 0.0066 0.01 99.96 CM21

Chloroquine 250mg Tab 133.59 10,378 0.0144 0.01 99.96 CM19

Pethidine 100mg/ml, 1ml Amp 131.21 60 0.2318 0.01 99.97 CH15

Paracetamol 325mg Tab 99.33 14,810 0.0067 0.00 99.97 CM1

Methylergometrine 0.125mg Tab 86.36 4,936 0.0079 0.00 99.97 CH5

Paracetamol 100mg/ml, 15ml Drop 79.03 368 0.0859 0.00 99.98 CM1

Phenobarbital 50mg/ml 5ml Amp 74.79 90 0.3290 0.00 99.98 CH16

Hydralazine 50mg Tab 69.21 20,355 0.0005 0.00 99.98 CM10

Digoxin 0.25mg Tab 57.28 3,931 0.0135 0.00 99.98 CH4

Fluoxetine 10mg Tab 57.12 1,781 0.0321 0.00 99.99 CM21

Hydrochlorothiazide 25mg Tab 56.19 9,636 0.0042 0.00 99.99 CM10


Digoxin 0.25mg/ml 2ml Amp 49.20 381 0.1694 0.00 99.99 CH4

Norgestrel 0.03mg Cycle 45.66 3,132 0.0073 0.00 100.00 CM11

Lidocaine 1% 20ml Vial 28.72 32 0.4488 0.00 100.00 CM7

Lidocaine 20mg/ml 5ml Amp 23.33 32 0.7290 0.00 100.00 CM7

28





Class

Pethidine 50mg/ml, 2ml Amp 23.33 4 0.7790 0.00 100.00 CH15

Chloroquine 40mg/ml, in 5ml Amp 16.74 170 0.0462 0.00 100.00 CM19

Methylergometrine 0.2mg/ml, 1ml Amp 13.73 351 0.0126 0.00 100.00 CH5


5.83 200 0.0194 0.00 100.00 CM11


Chloroquine 100mg Tab 0.00 0 0.0029 0.00 100.00 CM19

Hydralazine 25mg Tab 0.00 0 0.0000 0.00 100.00 CM10

Metoprolol 1mg/ml, in 5ml Amp 0.00 0 0.0000 0.00 100.00 CM10

Atropine Sulfate 1% in 5ml bottle, ophthalmic drop

0.00 0 0.0387 0.00 100.00 CH2

Atropine Sulfate 1mg Tab 0.00 0 0.0000 0.00 100.00 CH2

Paracetamol (Acetaminophen) 225mg/3ml, Amp (75mg/ml)

0.00 0 0.1312 0.00 100.00 CM1

Mebendazole 500mg Tab 0.00 0 0.0050 0.00 100.00 CM2

Spironolactone 100mg Tab 0.00 0 0.1223 0.00 100.00 CM10

Lidocaine 1% 50ml Vial 0.00 0 0.0000 0.00 100.00 CM7

Zinc Sulfate 10mg Tab 0.00 0 0.0000 0.00 100.00 CM15

Isoniazid 300mg Tab (INH) 0.00 0 0.0000 0.00 100.00 CM4

Retinol (Vit A) 100,000 IU Amp 0.00 0 0.0094 0.00 100.00 CM16

29

Table 4A. Quarterly Public Expenditures on Medicines per Patient/Client at BPHS/EPHS, by Province


This table shows the quarterly public expenditure on medicines per patient/client at the BPHS/EPHS level in the provinces. It was between US$ 0.05 (Kabul) and US$ 0.81 (Badakhshan) with the overall average of US$ 0.31. This information reveals that quarterly public expenditure on medicines per patient/client at the BPHS/EPHS level is very low. The total number of patients/clients was obtained from HMIS data for the same quarter.

Province Total Patients/clients Value of Medicines Consumed in US$

Average Medicine Expenditure in US$

Badakhshan 537,257 433,416.83 0.81

Badghis 302,530 40,770.86 0.13

Baghlan 453,779 148,767.66 0.33

Balkh 777,917 129,863.83 0.17

Bamyan 339,755 121,014.11 0.36

Dykundi 359,564 144,206.52 0.40

Farah 329,396 66,594.69 0.20

Faryab 590,063 166,986.88 0.28

Ghazni 544,276 249,730.59 0.46

Ghor 363,398 198,193.24 0.55

Helmand 600,409 140,948.75 0.23

Hirat 953,755 105,390.93 0.11

Jawzjan 424,809 64,193.34 0.15

Kabul 1,522,616 68,521.61 0.05

Kandahar 631,685 187,608.48 0.30

Khost 379,043 88,015.47 0.23

Kunar 431,787 163,751.88 0.38

Kunduz 431,656 138,965.81 0.32

Laghman 379,067 94,072.37 0.25

Logar 344,250 188,677.49 0.55

*Definition of "Total Patient/client": total number of new, <5, >5, male and female and revisits of out-patients and in-patients. Source: National Health Management Information System Procedures Manual Section III, Annex 2, Indicator 65. 30

Province Total Patients/clients Value of Medicines Consumed in US$

Average Medicine Expenditure in US$

Nangarhar 1,197,942 192,410.19 0.16

Nimroz 140,861 25,696.33 0.18

Nooristan 89,607 56,950.93 0.64

Paktika 247,132 69,142.59 0.28

Paktya 372,451 77,336.61 0.21

Samangan 277,669 105,781.07 0.38

Sar-e-Pul 323,030 55,759.80 0.17

Takhar 541,044 176,706.51 0.33

Urozgan 196,903 81,360.70 0.41

Wardak 382,070 141,725.26 0.37

Zabul 164,123 46,197.85 0.28

Overall 14,629,844 3,968,759.19 0.31

*Definition of "Total Patient/client": total number of new, <5, >5, male and female and revisits of out-patients and in-patients. Source: National Health Management Information System Procedures Manual Section III, Annex 2, Indicator 65. 31

Table 4B. Quarterly Public Expenditures on Medicines per Capita at BPHS/EPHS, by Province


This table reflects the quarterly public expenditure on medicines per capita at the BPHS/EPHS level in the provinces. It was between US$ 0.02 (Kabul) and US$ 0.51 (Logar). With the overall average of US$ 0.21. Estimated population data are obtained from the latest update of Afghanistan’s Central Statistics Office.

Province Population Value of Medicines Consumed in US$ Average Medicine Expenditure in US$

Badakhshan 904,700 433,416.83 0.48

Badghis 471,900 40,770.86 0.09

Baghlan 863,700 148,767.66 0.17

Balkh 1,245,100 129,863.83 0.10

Bamyan 425,500 121,014.11 0.28

Dykundi 438,500 144,206.52 0.33

Farah 482,400 66,594.69 0.14

Faryab 948,000 166,986.88 0.18

Ghazni 1,168,800 249,730.59 0.21

Ghor 657,200 198,193.24 0.30

Helmand 879,500 140,948.75 0.16

Hirat 1,780,000 105,390.93 0.06

Jawzjan 512,100 64,193.34 0.13

Kabul 3,950,300 68,521.61 0.02

Kandahar 1,151,100 187,608.48 0.16

Khost 546,800 88,015.47 0.16

Kunar 428,800 163,751.88 0.38

Kunduz 953,800 138,965.81 0.15

Laghman 424,100 94,072.37 0.22

Logar 373,100 188,677.49 0.51

Nangarhar 1,436,000 192,410.19 0.13

* Estimated population data for 2012-2013 from the Afghanistan’s Central Statistics Office (CSO) http://cso.gov.af/Content/files/Settled%20Population%20by%20Civil%20Division,.pdf 32

Province Population Value of Medicines Consumed in US$ Average Medicine Expenditure in US$

Nimroz 156,600 25,696.33 0.16

Nooristan 140,900 56,950.93 0.40

Paktika 413,800 69,142.59 0.17

Paktya 525,000 77,336.61 0.15

Samangan 368,800 105,781.07 0.29

Sar-e-Pul 532,000 55,759.80 0.10

Takhar 933,700 176,706.51 0.19

Urozgan 333,500 81,360.70 0.24

Wardak 567,600 141,725.26 0.25

Zabul 289,300 46,197.85 0.16

Overall 24,302,600 3,968,759.19 0.21

* Estimated population data for 2012-2013 from the Afghanistan’s Central Statistics Office (CSO) http://cso.gov.af/Content/files/Settled%20Population%20by%20Civil%20Division,.pdf 33

Table 5A. Average HF Days of Stock-out for Each Medicine 1Quarter , 1395 (Hamal - Jawza)

This table shows the average days of stock-out of each medicine among health facilities. The current version of PLIS is not able to provide the exact number of days of medicine stock-outs within HFs. This table is to provide highlights of the general extent of stock-out of the medicines within HFs.

Medicine Name Total Days of Stock out Total HFs Average Days

Acetylcysteine 200mg/5ml granules for syr 30 1640 0.02

Acetylsalicylic acid (Aspirin) 100mg tab 2045 1640 1.25

Acetylsalicylic acid (Aspirin) 500mg tab 4147 1640 2.53

Aciclovir 3% 15g Oint 19 1640 0.01

Activated charcoal 250mg tab 396 1640 0.24

Adrenalin 0.0005%+Lidocaine 2% in 50ml vial 241 1640 0.15

Adrenalin 0.00125%+Lidocaine dental 1% Amp 2419 1640 1.48

Adrenalin 0.00125%+Lidocaine dental 2% injection solution

25 1640 0.02

Adrenalin 1:200,000 (0.0005%)+Lidocaine 1% Amp 120 1640 0.07

Albendazole 200mg tab 380 1640 0.23

Albendazole 400mg tab 2022 1640 1.23

Alcuronium Injection, 5mg/ml in 2ml Amp 458 1640 0.28

Allopurinol 100mg tab 30 1640 0.02

Alprazolam 0.5mg tab 4400 1640 2.68

Aluminium hydroxide 200mg+Magnesium hydroxide 200mg tab

10619 1640 6.48

Aluminium hydroxide 225mg+Magnesium hydroxide 200mg/5ml, 200ml/bottle, susp

1830 1640 1.12

Aluminium hydroxide 500mg tab 1039 1640 0.63

Aminophylline 100mg tab 3292 1640 2.01

Aminophylline 25mg/ml, in 10ml Amp 1612 1640 0.98

Amitriptylline 25mg tab 3236 1640 1.97

Amoxicillin 125mg/5ml, in 60ml bottle, susp 784 1640 0.48

Amoxicillin 250mg Cap 4234 1640 2.58

Amoxicillin 250mg/5ml, in 60ml bottle, Susp 1338 1640 0.82

Amoxicillin 500mg Cap 4053 1640 2.47

Amoxicillin 500mg+Clavulanic acid 125mg (Co-amoxiclav) Tab

22 1640 0.01

Type of HFs include: RH, PH, DH, CHC, BHC, SHC, MHT and Other. 34


Ampicillin 1g vial 3079 1640 1.88

Ampicillin 500mg vial 3625 1640 2.21

Antitetanus Immunoglobulin 1500IU/1ml, in 1ml Amp

186 1640 0.11

Artemether 100mg/ml, 1ml Amp 4 1640 0.00

Artemether 20mg/ml, 1ml Amp 2345 1640 1.43

Artemether 80mg/ml, 1ml, Amp 58 1640 0.04


200 1640 0.12


237 1640 0.14


251 1640 0.15


150 1640 0.09


636 1640 0.39

Atenolol 100mg Tab 1304 1640 0.80

Atenolol 50mg Tab 2310 1640 1.41

Atropine Sulfate 1% in 5ml bottle, ophthalmic drop 90 1640 0.05

Atropine sulfate 1mg/ml, in 1ml Amp 620 1640 0.38

Bacitracin 500IU+Neomycin 5mg/g, 15g topical Oint 20 1640 0.01

Benzoic Acid 6%+Salicylic acid 3% topical Oint 1822 1640 1.11

Betamethasone 0.1% in 15g tube, topical Oint 521 1640 0.32

Betamethasone 0.1%+Neomycine 0.5% in 10ml bottle, ophthalmic drop

106 1640 0.06

Betamethasone 0.1%+Neomycine 0.5% in 15g tube, topical cream

8 1640 0.00

Biperiden 5mg/ml 1ml Amp 90 1640 0.05

Bisacodyl 5mg Tab 772 1640 0.47

Bupivacaine 0.25% in 10ml Amp 100 1640 0.06

Calamine (ZnO + Fe2O3) 8% in 60ml bottle, topical lotion

29 1640 0.02

Calcium Gluconate 10% 10ml Amp 1194 1640 0.73

Carbamazepine 200mg Tab 613 1640 0.37

Cefotaxime 500mg Vial 30 1640 0.02



Ceftriaxone 1g Vial 898 1640 0.55

Ceftriaxone 500mg Vial 1380 1640 0.84

Cetrimide 15%+Chlorhexidine gluconate 1.5% topical Sol

1422 1640 0.87

Chloramphenicol 0.5% in 2.5ml bottle, ophthalmic drop

54 1640 0.03

Chloramphenicol 1%, 3.5g eye Oint 10 1640 0.01

Chloramphenicol 125mg/5ml 100ml Bottle Susp 1793 1640 1.09

Chloramphenicol 1g Vial 1629 1640 0.99

Chloramphenicol 250mg Cap 1595 1640 0.97

Chlorhexidine Digluconate 5% Topical Sol 777 1640 0.47

Chlorine Powder 8 1640 0.00

Chloroquine 150mg Tab 5150 1640 3.14

Chloroquine 50mg/5ml 60ml Syr 470 1640 0.29

Chlorphenamine maleate 10mg/ml , in 1ml Amp 898 1640 0.55

Chlorphenamine maleate 4mg Tab 7367 1640 4.49

Chlorpromazine 100mg Tab 148 1640 0.09

Chlorpromazine 25mg/ml, 2ml Amp 139 1640 0.08

Chlorpromazine 50mg/ml, 2ml Amp 30 1640 0.02

Cimetidine 100mg/ml 2ml Amp 90 1640 0.05

Ciprofloxacin 250mg Tab 1362 1640 0.83

Ciprofloxacin 2mg/ml 50ml Vial 164 1640 0.10

Ciprofloxacin 500mg Tab 710 1640 0.43

Clotrimazole 1% in 45g tube, vaginal cream 448 1640 0.27

Cloxacillin 250mg Cap 1730 1640 1.05

Cloxacillin 500mg Cap 666 1640 0.41

Cloxacillin 500mg Vial 439 1640 0.27

Colecalciferol (Vit D3) 600,000IU/ml Amp 65 1640 0.04

Condom 2438 1640 1.49

Diazepam 10mg Tab 1600 1640 0.98

Diazepam 5mg Tab 2150 1640 1.31

Diazepam 5mg/ml 2ml Amp 1926 1640 1.17



Diclofenac 25mg/ml 3ml Amp 2157 1640 1.32

Diethylcarbamazine citrate 100mg Tab 120 1640 0.07

Diethylcarbamazine citrate 50mg Tab 90 1640 0.05

Digoxin 0.25mg Tab 345 1640 0.21

Digoxin 0.25mg/ml 2ml Amp 169 1640 0.10

Diphenhydramine chloride 14mg/5ml, 90ml Syr 30 1640 0.02

Diphenhydramine chloride 50mg Tab 20 1640 0.01

Diphenhydramine chloride 5mg/5ml, 60ml, Syr 50 1640 0.03

Dopamine 40mg/ml 5ml Amp 13 1640 0.01

Doxycycline 100mg Cap 4286 1640 2.61

Enoxaparin 100mg/ml, 1ml Amp 17 1640 0.01

Enoxaparin 6000 IU(60mg)/0.6ml in Prefilled syringe (PFS) or Amp

90 1640 0.05

Ephedrine Hcl 5mg/ml, in 10ml , Amp 52 1640 0.03

Epinephrine (Adrenaline) 0.1% in 1ml Amp 596 1640 0.36

Ergometrine 0.2mg Tab 2231 1640 1.36

Ergometrine 0.2mg/ml, 1ml Amp 2105 1640 1.28

Erythromycin (Base) 200mg/5ml, in 60ml, susp 488 1640 0.30

Erythromycin (Ethyl Succinate) 100mg/ml 100ml Susp 976 1640 0.60

Erythromycin Stearate 250mg Tab 1620 1640 0.99

Erythromycin Stearate 500mg Tab 1390 1640 0.85

Ethambutol (EMB) 400mg Tab 2603 1640 1.59

Ethambutol 400mg+Isoniazid 150mg Tab (EH) 2118 1640 1.29

Ethinylestradiol 0.035mg+Norethisterone 1mg Cycle 2588 1640 1.58

Ethinylestradiol 0.03mg+Levonorgestrel 0.15mg Cycle 2168 1640 1.32

Ethinylestradiol 0.05mg+Levonorgestrel 0.25mg Cycle 2588 1640 1.58

Famotidine 40mg Tab 30 1640 0.02

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.25mg Tab 25 1640 0.02

Ferrous Sulfate 25mg/ml 120ml Drop 1806 1640 1.10

Ferrous Sulfate 60mg Tab 2494 1640 1.52

Ferrous Sulphate 200mg Tab 490 1640 0.30



Ferrous Sulphate 60mg+Folic Acid 0.4mg Tab 12661 1640 7.72

Flumazenil 0.1mg/ml, in 10ml , Amp 7 1640 0.00

Fluorescein 1% in 5ml bottle, ophthalmic drop 4 1640 0.00

Fluoxetine 20mg Cap 2621 1640 1.60

Fluphenazine 25mg/ml, 1ml Amp 90 1640 0.05

Folic Acid 1mg Tab 2480 1640 1.51

Folic Acid 5mg Tab 10590 1640 6.46

Furosemide 10mg/ml, in 2ml Amp 323 1640 0.20

Furosemide 20mg Tab 330 1640 0.20

Furosemide 40mg Tab 710 1640 0.43

Gentamicin 10mg/ml, 2ml Amp 3313 1640 2.02



Glibenclamide 5mg Tab 4750 1640 2.90

Glucose 10% 1000ml IV infusion 77 1640 0.05


Glucose 25% 20ml, Amp 74 1640 0.05

Glucose 4%+Sodium Chloride 0.18% 500ml IV infusion

1862 1640 1.14



Glucose 5%+Sodium Chloride 0.9% 1000ml IV infusion

1501 1640 0.92

Glucose 5%+Sodium Chloride 0.9% 500ml IV infusion 120 1640 0.07

Glucose 50% 50ml IV 523 1640 0.32

Griseofulvin 125mg Tab 560 1640 0.34

Haloperidol 5mg Tab 4540 1640 2.77

Haloperidol 5mg/ml, 1ml Amp 115 1640 0.07

Halothane 250ml Inhaler 2 1640 0.00

Heparin 5000IU/ml 1ml Amp 34 1640 0.02

Hydralazine 20mg/ml, in 2ml , Amp 78 1640 0.05

Hydrochlorothiazide 25mg Tab 1800 1640 1.10



Hydrochlorothiazide 50mg Tab 2650 1640 1.62

Hydrocortisone Sodium Succinate 100mg Vial 2249 1640 1.37

Hydrogen peroxide 6% topical Solution 63 1640 0.04

Hyoscine (butylbromide,hydrobromide) 10mg Tab 1230 1640 0.75

Hyoscine (butylbromide,hydrobromide) 20mg/ml, in 1ml Amp

570 1640 0.35

Ibuprofen 200mg Tab 6877 1640 4.19

Ibuprofen 400 mg Tab 6050 1640 3.69

Insulin (70/30) 100 IU/ml, 10ml Vial 23 1640 0.01

Intrauterine device (IUD) with copper 1pce , vaginal intra uterine device

240 1640 0.15

Iodine 200mg Cap 114 1640 0.07

Iodine 480mg/ml, in 0.5ml Amp 640 1640 0.39

Iodine 540mg/ml, in 0.57ml bottle 28 1640 0.02

Isoniazid 100mg Tab (INH) 2226 1640 1.36

Isosorbide Dinitrate 10mg Tab 30 1640 0.02

Isosorbide Dinitrate 5mg Tab 1090 1640 0.66

Ketamin 50mg/ml 10ml Vial 839 1640 0.51

Ketoconazole 2% 15g Oint 12 1640 0.01

Ketoconazole 200mg Tab 86 1640 0.05

Lidocaine 1% in 2ml Amp 300 1640 0.18

Lidocaine 2% in 15g tube, topical gel 1543 1640 0.94

Lidocaine 2% in 20ml Vial 1023 1640 0.62

Lidocaine 4% cream/Oint 29 1640 0.02

Lidocaine 5% 2ml Amp 120 1640 0.07

Lindane 1% in 100ml bottle, topical lotion 483 1640 0.29

Magnesium Sulfate 500mg/ml (50%) 10ml Amp 730 1640 0.45

Mannitol 10 % 500ml Infusion 30 1640 0.02

Mebendazole 100mg Tab 4410 1640 2.69


976 1640 0.60

Meglumine antimoniate 30%, 5ml Amp (Meglusan 1.5g, 8.1% antimony)

194 1640 0.12



Metformin 500mg Tab 1600 1640 0.98

Methanol 70% 60ml Sol 32 1640 0.02

Methyldopa 250mg Tab 2258 1640 1.38

Methylergometrine 0.2mg/ml, 1ml Amp 23 1640 0.01

Methylrosaniline (Gentian Violet) 0.5% in 10ml bottle, topical Sol

898 1640 0.55

Methylrosaniline (Gentian Violet) 1% in 10ml bottle, topical Sol

1458 1640 0.89

Metoclopramide 10mg Tab 3502 1640 2.14

Metoclopramide 5mg/ml, in 2ml Amp 1486 1640 0.91

Metronidazole 120mg/5ml, in 100ml bottle, Susp 917 1640 0.56

Metronidazole 200mg Tab 6954 1640 4.24

Metronidazole 200mg/5ml, in 100ml bottle, Susp 181 1640 0.11

Metronidazole 400mg Tab 6818 1640 4.16

Metronidazole 5mg/ml, in 100ml bottle, infusion Sol 1417 1640 0.86

Misoprostol 200mcg Tab 12 1640 0.01


566 1640 0.35

Multivitamin Tab 12266 1640 7.48

Naloxone 400mcg/ml (0.4mg/ml) in 1ml Amp 430 1640 0.26

Naphazoline 0.05% in 10ml bottle, nasal drop 20 1640 0.01

Neostigmine methylsulfate 0.5mg/ml, in 10ml Amp 526 1640 0.32

Nifedipine 10mg Tab/Cap 478 1640 0.29

Nitrofurantoin 100mg Tab/Cap 2577 1640 1.57

Norethindrone 0.35mg (Progestin-Only Pills or Mini-Pills)

2612 1640 1.59

Norgestrel 0.075mg Cycle 574 1640 0.35

Nystatin 100,000IU 15g Vaginal Oint 1850 1640 1.13

Nystatin 100,000IU 30ml Oral Topical Drop 1844 1640 1.12

Nystatin 100,000IU Oral Tab 1917 1640 1.17

Nystatin 100,000IU Vaginal Tab/ovule suppository 3505 1640 2.14

Nystatin 500,000IU Tab, oral 2099 1640 1.28

Omeprazole 20mg Cap 3871 1640 2.36




4077 1640 2.49

Oxytocine 10IU/ml in 1ml Amp 3027 1640 1.85


30 1640 0.02

Paracetamol 100mg Tab 17187 1640 10.48

Paracetamol 100mg/ml, 15ml Drop 208 1640 0.13

Paracetamol 120mg/5ml, 60ml Syr 1294 1640 0.79



Penicillin Benzyl (Peni G crystal) 1MU Vial 18 1640 0.01

Penicillin Benzyl (Peni G crystal) 5MU Vial 80 1640 0.05

Penicillin Benzyl Benzathine 1.2MU Vial 392 1640 0.24

Penicillin Benzyl Benzathine 2.4MU Vial 693 1640 0.42

Penicillin Benzyl Procaine 2MU Vial 409 1640 0.25



Penicillin V Potassium 250mg Tab 2438 1640 1.49

Penicillin V Potassium 500mg Tab 4169 1640 2.54

Penicillin V(Phenoxy methyl Penicillin) 250mg/5ml, in 100ml bottle, Susp

1393 1640 0.85

Pethidine 100mg Tab 90 1640 0.05

Pethidine 100mg/ml, 1ml Amp 90 1640 0.05

Pethidine 50mg Tab 90 1640 0.05

Pethidine 50mg/ml, 2ml Amp 90 1640 0.05

Phenobarbital 100mg Tab 1293 1640 0.79

Phenobarbital 15mg Tab 1289 1640 0.79

Phenobarbital 200mg/ml, 1ml Amp 287 1640 0.18

Phenobarbital 50mg/ml 5ml Amp 90 1640 0.05

Phytomenadione (Vit K) 10mg/2ml, Amp 432 1640 0.26

Phytomenadione (Vit K) 10mg/ml, 5ml Amp (50mg/5ml)

894 1640 0.55

Potassium Chloride 11.2% 20ml Amp 1717 1640 1.05



Potassium permanganate 0.01% topical Sol 16 1640 0.01

Potassium permanganate powder 90 1640 0.05

Povidone-Iodine 10% Topical Sol 985 1640 0.60

Prednisolone 0.5% 5ml eye Drops 30 1640 0.02

Prednisolone 5mg Tab 1939 1640 1.18

Primaquine 15mg Tab 571 1640 0.35

Promethazine 25mg Tab 90 1640 0.05

Propranolol 10mg Tab 1366 1640 0.83



Protamine Sulfate 10mg/ml 5ml Amp 140 1640 0.09

Pyrazinamide (PZA) 500mg Tab 2806 1640 1.71

Pyridoxine (Vit B6) 40mg Tab 1960 1640 1.20

Pyrimethamine 25mg+Sulfadoxine 500mg Tab 469 1640 0.29

Quinine dihydrochloride 300mg/ml, in 2ml Amp 2935 1640 1.79

Quinine Sulfate 300mg Tab 854 1640 0.52

Ranitidine 150mg Tab 3202 1640 1.95

Ranitidine 25mg/ml, in 2ml Amp 88 1640 0.05

Ranitidine 300mg Tab 2240 1640 1.37

Retinol (Vit A) 100,000 IU Amp 90 1640 0.05

Retinol (Vit A) 100,000 IU Tab 398 1640 0.24

Retinol (Vit A) 200,000 IU Cap 1951 1640 1.19

Rifampicin 150mg+Isoniazid 75mg (RH) Tab 2383 1640 1.45


2228 1640 1.36


2355 1640 1.44

Rifampicin 60mg+Isoniazid 30mg (RH) Tab 2384 1640 1.45


2426 1640 1.48

Ringer lactate 1000ml IV infusion 2616 1640 1.60

Ringer lactate 500ml IV infusion 555 1640 0.34



Salbutamol 0.05mg/ml (50mcg/ml) in 5ml Amp 944 1640 0.58

Salbutamol 0.1mg/dose 200 dose Bottle Inhalation Sol

1591 1640 0.97

Salbutamol 0.5mg/ml, in 1ml Amp 567 1640 0.35

Salbutamol 2mg Tab 645 1640 0.39

Salbutamol 2mg/5ml, in 60ml bottle, Syr 2786 1640 1.70

Salbutamol 4mg Tab 8829 1640 5.38

Salbutamol 5mg/ml in 20ml Inhalation Sol 30 1640 0.02

Salbutamol 5mg/ml in 30ml Inhalation Sol 206 1640 0.13

Salicylic Acid 5% Oint 90 1640 0.05

Silver sulfadiazine 1% in 250g container, topical cream

310 1640 0.19

Silver sulfadiazine 1% in 30g tube, topical cream 876 1640 0.53

Silver sulfadiazine 1% in 50g tube, topical cream 865 1640 0.53

Silver Sulfadiazine 1% Oint 781 1640 0.48

Sodium Bicarbonate 8.4% 10ml Amp 506 1640 0.31

Sodium Bicarbonate 8.4% 20ml Amp 60 1640 0.04


1439 1640 0.88

Sodium Stibogluconate 100mg/ml, 30ml Vial 576 1640 0.35


5078 1640 3.10


1032 1640 0.63


5313 1640 3.24

Suxamethonium 50mg/ml 2ml Amp 285 1640 0.17

Tetracaine 0.5% 15ml Eye Drop 817 1640 0.50

Tetracycline Eye 1% Oint 1645 1640 1.00

Thiopental Sodium 500mg Vial 412 1640 0.25

Tramadol 100mg Tab 30 1640 0.02

Tramadol 100mg/2ml, Amp 60 1640 0.04

Tramadol 50mg/ml, in 2ml Amp 317 1640 0.19

Trihexyphenidyl 2mg Tab 518 1640 0.32



Tuberculin Purified 10IU/ml, in 1ml Amp 90 1640 0.05

Valproic Acid (Sodium valproate) 200mg Tab 73 1640 0.04

Valproic Acid (Sodium valproate) 500mg Tab 21 1640 0.01

Water for Injection 10ml Amp 70 1640 0.04

Water for Injection 5ml Amp 10416 1640 6.35

Zinc Oxide 20% 20g Oint 45 1640 0.03

Zinc Sulfate 20mg Tab 3954 1640 2.41


Table 6. The Summary of the Overall Volume Indicators for HMIS Indicator Medicines

1Quarter ,1395 (Hamal - Jawza)

This table shows the summary of overall quantities (volume indicators) flow between the three levels of supply chain for HMIS indicator medicines. The data reveals that paracetamol 500mg tab had the highest consumed quantity ( 22,561,537 tabs) in the reporting quarter.

Medicines Beginning Stock Added Stock Grand Total Available

Donated Out Consumed quantity Reported Wastage Reported Ending Stock

Acetylsalicylic acid (Aspirin) 100mg tab 904,386 302,612 1,206,998 2,080 475,445 1,000 1,007,745

Acetylsalicylic acid (Aspirin) 300mg tab 100,940 5,000 105,940 0 60,560 0 81,380

Acetylsalicylic acid (Aspirin) 500mg tab 6,362,485 2,380,676 8,743,161 2,000 4,857,806 16,863 6,655,933

Amitriptylline 10mg tab 19,460 11,450 30,910 0 24,500 0 6,410

Amitriptylline 25mg tab 2,529,515 764,360 3,293,875 0 1,018,006 59,626 2,618,973

Amoxicillin 125mg/5ml, in 60ml bottle, susp 171,331 33,102 204,433 0 96,904 1 158,962

Amoxicillin 250mg Cap 12,199,644 3,119,033 15,318,677 0 8,135,550 36,200 10,839,855

Amoxicillin 250mg/5ml, in 60ml bottle, Susp 214,972 67,788 282,760 0 161,487 1,224 173,217

Amoxicillin 500mg Cap 13,141,042 4,435,102 17,576,144 90 9,709,950 28,130 12,475,307

Ampicillin 1g vial 423,291 138,257 561,548 0 323,314 710 380,345

Ampicillin 500mg Tab 47,107 3,000 50,107 0 29,886 0 32,847

Ampicillin 500mg vial 450,356 124,315 574,671 0 274,868 920 508,622


17,435 328 17,763 0 1,820 786 16,470


3,279 472 3,751 0 1,092 154 2,409


2,352 239 2,591 0 250 4 2,485


26,445 1,107 27,552 0 5,081 1,960 22,403


33,725 228 33,953 0 2,180 8 33,082

Atenolol 100mg Tab 238,096 63,243 301,339 0 172,141 16 279,495

45



Atenolol 50mg Tab 840,522 252,029 1,092,551 1,400 411,442 526 820,157

Atropine Sulfate 1% in 5ml bottle, ophthalmic drop 0 0 0 0 0 0 0

Atropine Sulfate 1mg Tab 0 0 0 0 0 0 0

Atropine sulfate 1mg/ml, in 1ml Amp 54,227 3,811 58,038 121 14,512 165 46,290

Captopril 25mg Tab 21,930 0 21,930 0 10,330 0 10,200

Chloroquine 100mg Tab 0 0 0 0 0 0 0

Chloroquine 150mg Tab 1,817,551 258,082 2,075,633 640 597,962 19,858 1,757,568

Chloroquine 250mg Tab 29,453 17,000 46,453 0 10,378 0 48,341

Chloroquine 40mg/ml, in 5ml Amp 231 0 231 0 170 0 61

Chloroquine 50mg/5ml 60ml Syr 77,700 10,507 88,207 20 18,915 3,777 68,759

Chloroquine Phosphate 300mg Tab 111,777 0 111,777 0 18,297 2,042 107,128

Condom 3,583,270 651,032 4,234,302 1,200 1,786,290 16,890 2,990,088

Diazepam 5mg/ml 2ml Amp 72,215 17,365 89,580 3 40,928 489 60,879

Digoxin 0.25mg Tab 19,343 681 20,024 0 3,931 0 22,550

Digoxin 0.25mg/ml 2ml Amp 5,306 239 5,545 0 381 5 5,659

Ergometrine 0.2mg Tab 687,227 97,659 784,886 196 275,231 1,915 722,567

Ergometrine 0.2mg/ml, 1ml Amp 50,878 21,807 72,685 182 18,974 2,047 62,892

Ethinylestradiol 0.035mg+Norethisterone 1mg Cycle 11,467 16,000 27,467 0 20,499 0 8,468

Ethinylestradiol 0.03mg+Levonorgestrel 0.15mg Cycle 811,849 87,993 899,842 0 344,514 15,285 613,761

Ethinylestradiol 0.03mg+Norgestrel 0.3mg Cycle 66,476 160 66,636 8,590 10,840 6,551 54,744

Ethinylestradiol 0.05mg+Levonorgestrel 0.25mg Cycle 0 2,300 2,300 0 200 0 2,100

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.25mg Tab 8,562,248 4,861,400 13,423,648 0 9,826,426 36,017 6,191,881

Ferrous sulfate 200mg+Folic acid (Vit B9) 0.4mg Tab 2,887,692 2,087,000 4,974,692 0 4,015,370 6,000 2,645,692

46



Ferrous sulfate 200mg+Folic acid (Vit B9) 0.5mg Tab 403,535 5,000 408,535 0 102,750 0 305,785

Ferrous Sulphate 60mg+Folic Acid 0.4mg Tab 11,161,909 3,673,258 14,835,167 0 6,643,301 4,000 10,713,636

Fluoxetine 10mg Tab 5,231 0 5,231 0 1,781 0 4,194

Fluoxetine 20mg Cap 1,858,631 370,414 2,229,045 58,000 869,574 2,000 1,577,189

Furosemide 10mg/ml, in 2ml Amp 66,048 3,346 69,394 0 23,110 164 53,721

Furosemide 20mg Tab 152,317 39,625 191,942 0 47,940 0 175,987

Furosemide 40mg Tab 419,048 10,030 429,078 30 117,027 800 334,388

Gentamicin 10mg/ml, 2ml Amp 139,911 25,622 165,533 0 69,145 580 126,603



Hydralazine 20mg/ml, in 2ml , Amp 12,066 937 13,003 12 2,371 0 12,002

Hydralazine 25mg Tab 0 0 0 0 0 0 0

Hydralazine 50mg Tab 0 0 0 0 20,355 0 3,041

Hydrochlorothiazide 25mg Tab 21,727 0 21,727 0 9,636 590 12,701

Hydrochlorothiazide 50mg Tab 1,550,266 172,087 1,722,353 1,095 611,039 3,553 1,331,649

Isoniazid 100mg Tab (INH) 142,066 5,574 147,640 0 21,832 336 126,392

Isoniazid 300mg Tab (INH) 0 0 0 0 0 0 0

Ketamin 50mg/ml 10ml Vial 19,587 1,200 20,787 75 5,805 1,249 16,179

Lidocaine 1% 20ml Vial 98 0 98 0 32 0 226

Lidocaine 1% 50ml Vial 0 0 0 0 0 0 0

Lidocaine 1% in 2ml Amp 6,221 33 6,254 0 1,674 0 5,469

Lidocaine 2% in 20ml Vial 19,771 4,745 24,516 0 11,435 103 19,494

Lidocaine 2% in 2ml Amp 28,592 8,815 37,407 0 10,901 0 28,636

47



Lidocaine 2% in 50ml Vial 4,821 1,310 6,131 0 1,906 0 4,176

Lidocaine 20mg/ml 5ml Amp 32 46 78 0 32 0 46

Lidocaine 5% 2ml Amp 8,531 0 8,531 0 2,751 20 7,270

Magnesium Sulfate 500mg/ml (50%) 10ml Amp 37,933 2,412 40,345 100 5,984 163 36,718

Magnesium Sulfate 500mg/ml (50%) 20ml Amp 8,699 1,028 9,727 0 1,622 132 9,875

Mebendazole 100mg Tab 2,594,277 1,053,908 3,648,185 4,980 1,676,672 2,550 2,652,302

Mebendazole 500mg Tab 0 0 0 0 0 0 0


445,726 38,878 484,604 0 130,319 9,739 469,267

Methyldopa 250mg Tab 3,150,628 942,829 4,093,457 4,000 1,587,793 7,000 3,069,324

Methylergometrine 0.125mg Tab 23,385 0 23,385 0 4,936 0 18,849

Methylergometrine 0.2mg/ml, 1ml Amp 1,169 0 1,169 0 351 0 2,018

Metoprolol 1mg/ml, in 5ml Amp 0 0 0 0 0 0 600

Metronidazole 120mg/5ml, in 100ml bottle, Susp 33,380 0 33,380 0 23,382 0 20,659

Metronidazole 120mg/5ml, in 60ml bottle, Susp 1,960 0 1,960 0 3,483 181 1,517

Metronidazole 125mg/5ml, in 100ml bottle, Susp 35,421 16,856 52,277 0 37,547 1,210 22,020

Metronidazole 200mg Tab 8,593,348 2,373,276 10,966,624 10,800 5,068,546 28,000 8,787,805

Metronidazole 200mg/5ml, in 100ml bottle, Susp 236,665 98,508 335,173 0 155,108 1,270 225,748

Metronidazole 200mg/5ml, in 60ml bottle, Susp 60,930 7,573 68,503 0 40,550 0 53,211

Metronidazole 250mg Tab 10,000 0 10,000 0 48,963 0 47,437

Metronidazole 400mg Tab 7,369,927 3,607,907 10,977,834 0 4,847,588 20 8,945,337

Metronidazole 500mg Tab 0 0 0 0 38,962 0 20,338

Metronidazole 5mg/ml, in 100ml bottle, infusion Sol 92,541 20,899 113,440 0 70,704 4 69,823


6,737 1,460 8,197 0 3,049 0 5,959

48



Naloxone 400mcg/ml (0.4mg/ml) in 1ml Amp 15,427 1,005 16,432 0 4,804 125 12,534

Nifedipine 10mg Tab/Cap 546,928 84,140 631,068 516 208,262 1,020 545,089

Nifedipine 20mg Tab/Cap 58,681 0 58,681 0 19,278 0 51,028

Norgestrel 0.03mg Cycle 132 0 132 0 3,132 0 0

Norgestrel 0.075mg Cycle 106,497 5,970 112,467 5,766 35,202 12,142 80,347


2,819,636 844,474 3,664,110 0 1,742,326 10,600 2,495,581


1,340,529 257,400 1,597,929 0 930,228 0 1,036,050

Oxytocine 10IU/ml in 1ml Amp 443,273 88,735 532,008 6,180 241,226 4,634 339,288


0 0 0 0 0 0 0

Paracetamol 100mg Tab 10,905,859 5,130,372 16,036,231 15,080 9,480,534 31,300 11,919,797

Paracetamol 100mg/ml, 15ml Drop 300 400 700 0 368 4 438

Paracetamol 120mg/5ml, 60ml Syr 427,638 106,786 534,424 0 250,176 602 390,601

Paracetamol 325mg Tab 6,090 20,000 26,090 0 14,810 0 12,280

Paracetamol 500mg Tab 28,988,393 10,704,000 39,692,393 4,000 22,561,537 43,596 27,967,376

Penicillin Benzyl (Peni G crystal) 1MU Vial 380 0 380 0 2,120 0 8,370

Penicillin Benzyl (Peni G crystal) 5MU Vial 20,305 2,752 23,057 0 12,778 525 15,691

Pethidine 100mg/ml, 1ml Amp 20 0 20 0 60 0 10

Pethidine 50mg/ml, 2ml Amp 0 0 0 0 4 0 87

Phenobarbital 100mg/ml, in 2ml Amp 4,793 337 5,130 0 2,606 165 3,540

Phenobarbital 200mg/ml, 1ml Amp 2,207 240 2,447 0 1,140 0 3,668

Phenobarbital 50mg/ml 5ml Amp 81 0 81 0 90 0 21

Povidone-Iodine 10% Topical Sol 16,411 4,125 20,536 39 12,092 24 18,780

49



Propranolol 10mg Tab 4,890 3,550 8,440 0 4,380 0 4,060



Quinine dihydrochloride 300mg/ml, in 2ml Amp 18,047 249 18,296 0 5,050 394 13,918

Ranitidine 25mg/ml, in 2ml Amp 12,750 831 13,581 0 7,188 0 4,558

Retinol (Vit A) 100,000 IU Amp 0 0 0 0 0 0 0

Retinol (Vit A) 100,000 IU Tab 515,565 38,798 554,363 0 220,900 0 437,417

Retinol (Vit A) 200,000 IU Cap 2,132,291 422,289 2,554,580 1,500 852,603 3,258 1,967,507

Retinol (Vit A) 50,000IU Cap 272,905 0 272,905 0 221,465 1,600 91,650

Rifampicin 150mg+Isoniazid 75mg (RH) Tab 212,426 221,056 433,482 0 237,079 55,051 212,584


91,005 11,244 102,249 9,628 29,163 0 71,774


222,105 113,316 335,421 27 151,329 0 227,801

Rifampicin 60mg+Isoniazid 30mg (RH) Tab 217,804 13,584 231,388 28,000 20,315 3,936 191,905


19,022 14,111 33,133 100 8,290 1,704 38,128

Ringer lactate 1000ml IV infusion 174,542 55,950 230,492 80 154,397 486 150,989

Ringer lactate 500ml IV infusion 125,319 12,620 137,939 0 49,922 0 111,003

Salbutamol 0.05mg/ml (50mcg/ml) in 5ml Amp 22,982 901 23,883 0 6,408 37 23,649

Salbutamol 0.5mg/ml, in 1ml Amp 11,620 1,032 12,652 0 3,457 95 10,138


145,751 62,826 208,577 0 114,040 280 135,517


24,719 70 24,789 0 11,190 0 17,666

Spironolactone 100mg Tab 1,800 0 1,800 0 0 0 1,800


11,260,375 3,532,788 14,793,163 0 6,349,531 24,797 12,476,297

50




309,708 91,587 401,295 0 208,209 3 314,517

Sulfamethoxazole 400mg+Trimethoprim 80mg 50ml Susp (Co-trimoxazole)

114,985 0 114,985 0 100,037 0 14,948


18,888,596 5,858,993 24,747,589 6,000 12,875,219 41,479 19,408,109

Zinc Sulfate 10mg Tab 0 0 0 0 0 0 0

Zinc Sulfate 20mg Tab 4,819,197 2,495,034 7,314,231 0 3,005,656 9,336 5,662,193

51

contents · 2017-01-26 · highlights for this reporting quarter in this reporting quarter, 21...

Documents